Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 25 Jul 22 424B7 Prospectus with selling stockholder info
- 13 Jun 22 424B3 Prospectus supplement
- 13 Jun 22 EFFECT Notice of effectiveness
- 8 Jun 22 POS AM Prospectus update (post-effective amendment)
- 8 Jun 22 424B3 Prospectus supplement
- 1 Jun 22 424B3 Prospectus supplement
- 17 May 22 424B3 Prospectus supplement
- 20 Apr 22 424B3 Prospectus supplement
- 20 Apr 22 EFFECT Notice of effectiveness
-
8 Apr 22 S-1 IPO registration
NRXP similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 31, 2022, with respect to the consolidated financial statements of NRx Pharmaceuticals, Inc., included herein and to the reference to our firm under the heading “Experts” in the registration statement.
Short Hills, NJ
April 8, 2022